| Primary information |
|---|
| sequence ID | Seq_8527 |
| Peptide sequence | TQPRGPPASSPAPAPKF |
| CancerPDF_ID | CancerPDF_ID829, CancerPDF_ID2007, CancerPDF_ID12474, |
| PMID | 19795908,21136997,26992070 |
| Protein Name | Zyxin,Zyxin,Zyxin |
| UniprotKB Entry Name | ZYX_HUMAN,ZYX_HUMAN,NA |
| Fluid | Plasma,Serum,Serum |
| M/Z | 569.3,1704.89475,1704.8948 |
| Charge | 3,1,NA |
| Mass (in Da) | NA,NA,1705.906284 |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,LC-MS |
| Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,LC-MS/MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,NA |
| Labelled/Label Free | Labelled,Label Free,Label Free |
| FDR | less than 7%,NA,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID829, CancerPDF_ID2007, CancerPDF_ID12474, |
| p-Value | NA,NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),SEQUEST and Maxquant |
| Length | 17,17,17 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Melanoma |
| Database | NCBI refseq Protein Database,SwissProt Database,SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | "34 normal, 12 patients",30 patients and 30 healthy controls,8 cancer samples and 4 healthy samples |
| Regulation | NA,NA,"Present in 4 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." |
| Validation | NA,Leave One out Cross validation,na |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | |